Mesoblast Limited vs Orion Office REIT Inc — how do they compare? Mesoblast Limited trades at $16.68 (market cap $2.21B), while Orion Office REIT Inc trades at $2.72 (market cap $158.01M). The key difference: Mesoblast Limited is far larger — about 14× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 2.89% dividend while Mesoblast Limited pays none. Which is the better fit depends on your goals.
| MESO | ONL | |
|---|---|---|
Market Cap | $2.21B | $158.01M |
Sector | Technology | Real Estate |
52-Week High | $20.96 | $3.04 |
52-Week Low | $12.88 | $1.93 |
Enterprise Value | $2.21B | $574.95M |
Dividend Yield | — | 2.89% |
Trailing returns across standard periods
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →